Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial

Abstract Background Each year, an estimated 15 million babies are born preterm, a global burden borne disproportionately by families in lower-income countries. Maternal HIV infection increases a woman’s risk of delivering prematurely, and antiretroviral therapy (ART) may compound this risk. While pr...

Full description

Bibliographic Details
Main Authors: Joan T. Price, Bellington Vwalika, Bethany L. Freeman, Stephen R. Cole, Helen B. Mulenga, Jennifer Winston, Felistas M. Mbewe, Elwyn Chomba, Lynne M. Mofenson, Dwight J. Rouse, Robert L. Goldenberg, Jeffrey S. A. Stringer
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Pregnancy and Childbirth
Subjects:
Preterm birth
Progesterone
17-alpha hydroxyprogesterone caproate
HIV
Antiretroviral therapy
Sub-Saharan Africa
Online Access:http://link.springer.com/article/10.1186/s12884-019-2224-8

Internet

http://link.springer.com/article/10.1186/s12884-019-2224-8

Similar Items